Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Botto

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Atherosclerosis|September 20, 2024
Is colchicine on its way to a place in the polypill for cardiovascular prevention?Fernando Botto, Sebastián Garcia-Zamora
Revista Espanola De Cardiologia (English Ed.)|April 12, 2019
Is the Evidence Provided by the SPRINT Trial Solid Enough to Support a Systolic Blood Pressure Threshold of 120 mmHg?Sebastián García-Zamora, Fernando Botto
International Journal of Cardiology|July 31, 2007
Transient left midventricular ballooning without apical involvementFernando Botto, Marcelo Trivi, Lucio T Padilla
Current Problems in Cardiology|June 26, 2026
Atherosclerosis as an evolutionary mismatch disease: from ancestral biology to cardiometabolic vulnerabilityFernando Botto, Sebastián Garcia-Zamora, Federico Bottaro
European Heart Journal. Acute Cardiovascular Care|April 15, 2026
Reperfusion in STEMI in low- and middle-income countries: setting priorities, not lowering standardsSebastián Garcia-Zamora, Cesar Rodrigo Zoni, Fernando Botto
The Journal of Bone and Joint Surgery. American Volume|July 20, 2012
Revisiting sample size: are big trials the answer?Giovanna A L Lurati Buse, Fernando Botto, P J Devereaux
Medicina|December 26, 2022
[Role of polypills in cardiovascular risk reduction in primary prevention]Fernando Botto, Carlos Tajer, Rafael Díaz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
SCAI Cardiogenic Shock Classification for Predicting In-Hospital and Long-Term Mortality in Acute Heart FailureLucrecia María Burgos, Rocío Consuelo Baro Vila, Fernando Botto, et al.
Journal of Human Hypertension|February 22, 2018
Frequency of early vascular aging and associated risk factors among an adult population in Latin America: the OPTIMO studyFernando Botto, Sebastian Obregon, Fernando Rubinstein, et al.
European Heart Journal|May 14, 2004
Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromesOscar Bazzino, Juan J Fuselli, Fernando Botto, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Atherosclerosis|September 20, 2024
Is colchicine on its way to a place in the polypill for cardiovascular prevention?Fernando Botto, Sebastián Garcia-Zamora
Revista Espanola De Cardiologia (English Ed.)|April 12, 2019
Is the Evidence Provided by the SPRINT Trial Solid Enough to Support a Systolic Blood Pressure Threshold of 120 mmHg?Sebastián García-Zamora, Fernando Botto
International Journal of Cardiology|July 31, 2007
Transient left midventricular ballooning without apical involvementFernando Botto, Marcelo Trivi, Lucio T Padilla
Current Problems in Cardiology|June 26, 2026
Atherosclerosis as an evolutionary mismatch disease: from ancestral biology to cardiometabolic vulnerabilityFernando Botto, Sebastián Garcia-Zamora, Federico Bottaro
European Heart Journal. Acute Cardiovascular Care|April 15, 2026
Reperfusion in STEMI in low- and middle-income countries: setting priorities, not lowering standardsSebastián Garcia-Zamora, Cesar Rodrigo Zoni, Fernando Botto
The Journal of Bone and Joint Surgery. American Volume|July 20, 2012
Revisiting sample size: are big trials the answer?Giovanna A L Lurati Buse, Fernando Botto, P J Devereaux
Medicina|December 26, 2022
[Role of polypills in cardiovascular risk reduction in primary prevention]Fernando Botto, Carlos Tajer, Rafael Díaz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
SCAI Cardiogenic Shock Classification for Predicting In-Hospital and Long-Term Mortality in Acute Heart FailureLucrecia María Burgos, Rocío Consuelo Baro Vila, Fernando Botto, et al.
Journal of Human Hypertension|February 22, 2018
Frequency of early vascular aging and associated risk factors among an adult population in Latin America: the OPTIMO studyFernando Botto, Sebastian Obregon, Fernando Rubinstein, et al.
European Heart Journal|May 14, 2004
Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromesOscar Bazzino, Juan J Fuselli, Fernando Botto, et al.
Pageof 4